Cargando…
Peptic activity and gastroduodenal mucosal damage.
This contribution reviews briefly the history of the discovery and characterization of peptic activity; secretory models and current concepts regarding the regulation of pepsinogen secretion; and evidence that pepsin is a necessary co-factor for gastroduodenal mucosal injury. Several animal studies...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588974/ https://www.ncbi.nlm.nih.gov/pubmed/9041694 |
_version_ | 1782161029770248192 |
---|---|
author | Raufman, J. P. |
author_facet | Raufman, J. P. |
author_sort | Raufman, J. P. |
collection | PubMed |
description | This contribution reviews briefly the history of the discovery and characterization of peptic activity; secretory models and current concepts regarding the regulation of pepsinogen secretion; and evidence that pepsin is a necessary co-factor for gastroduodenal mucosal injury. Several animal studies indicate that peptic activity is required for acid- and nonsteroidal anti-inflammatory drug-induced gastroduodenal ulceration. A more vigorous approach to the development of anti-peptic drugs for the treatment of peptic ulcer disease is encouraged. |
format | Text |
id | pubmed-2588974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Yale Journal of Biology and Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-25889742008-12-01 Peptic activity and gastroduodenal mucosal damage. Raufman, J. P. Yale J Biol Med Research Article This contribution reviews briefly the history of the discovery and characterization of peptic activity; secretory models and current concepts regarding the regulation of pepsinogen secretion; and evidence that pepsin is a necessary co-factor for gastroduodenal mucosal injury. Several animal studies indicate that peptic activity is required for acid- and nonsteroidal anti-inflammatory drug-induced gastroduodenal ulceration. A more vigorous approach to the development of anti-peptic drugs for the treatment of peptic ulcer disease is encouraged. Yale Journal of Biology and Medicine 1996 /pmc/articles/PMC2588974/ /pubmed/9041694 Text en |
spellingShingle | Research Article Raufman, J. P. Peptic activity and gastroduodenal mucosal damage. |
title | Peptic activity and gastroduodenal mucosal damage. |
title_full | Peptic activity and gastroduodenal mucosal damage. |
title_fullStr | Peptic activity and gastroduodenal mucosal damage. |
title_full_unstemmed | Peptic activity and gastroduodenal mucosal damage. |
title_short | Peptic activity and gastroduodenal mucosal damage. |
title_sort | peptic activity and gastroduodenal mucosal damage. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588974/ https://www.ncbi.nlm.nih.gov/pubmed/9041694 |
work_keys_str_mv | AT raufmanjp pepticactivityandgastroduodenalmucosaldamage |